Bayer Can Start to Look Beyond Litigation

Dow Jones
07/02

0645 GMT - Bayer's progress toward resolving U.S. litigation over its Roundup glyphosate-based weedkiller means investors' focus should start to shift to the fundamental aspects of the business, Deutsche Bank's Virginie Boucher-Ferte says in a research note. "Last week's Supreme Court ruling is pivotal to Bayer's multipronged approach to draw a line under its glyphosate liability," the analyst says. "All in all, we believe it should effectively cap the glyphosate exposure within existing provisions." The German group has a compelling growth profile in both its agricultural and pharmaceutical units, she adds. Deutsche Bank raises its recommendation on Bayer stock to buy from hold, lifting its target price to 60 euros from 45 euros. Shares closed at 49 euros, before news that Bayer plans to separate its Roundup business. (adria.calatayud@wsj.com)

 

(END) Dow Jones Newswires

July 02, 2026 02:45 ET (06:45 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10